Disproportionality analysis of drug-related interstitial lung disease in patients with head and neck squamous cell carcinoma: a signal mining study - Top-Institutions - MDSpire

Disproportionality analysis of drug-related interstitial lung disease in patients with head and neck squamous cell carcinoma: a signal mining study

  • By

  • Jie Ju

  • Zhongfen Liu

  • Lin Cao

  • Lina Xia

  • Pei Zhang

  • Yanfei Wang

  • July 13, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Washington University School of Medicine
    Washington University School of Medicine

    St. Louis, Missouri

    Key Differentiators

    • Oncology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology

  • #4

    Lucille P. Markey Cancer Center at the University of Kentucky
    Lucille P. Markey Cancer Center at the University of Kentucky

    Lexington, Kentucky

    Key Differentiators

    • Oncology

  • #5

    James Graham Brown Cancer Center
    James Graham Brown Cancer Center

    Louisville, Kentucky

    Key Differentiators

    • Oncology

Original Source(s)

Disproportionality analysis of drug-related interstitial lung disease in patients with head and neck squamous cell carcinoma: a signal mining study

  • by Jie Ju, Zhongfen Liu, Lin Cao, Lina Xia, Pei Zhang, Yanfei Wang

  • July 13, 2026

Related Content

Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma

HOX gene dysregulation in head and neck squamous cell carcinoma: mechanisms, clinical relevance, and future perspectives

The Rise in Homemade Sunscreen Trends and Future Impacts on Skin Cancer Risk: Systematic Review